Outcomes that matter to patients with cancer: living longer and living better

This publication has 33 references indexed in Scilit:

• Do drugs offering only PFS maintain quality of life sufficiently from a patient’s perspective? Results from AVALPROFS (Assessing the ‘VALue’ to patients of PROgression Free Survival) study
  Supportive Care in Cancer, 2018
• The Ethical Imperative And Moral Challenges Of Engaging Patients And The Public With Evidence
  Health Affairs, 2016
• Bias in progression‐free survival analysis due to intermittent assessment of progression
  Statistics in Medicine, 2015
• Treatment priorities in oncology: do we want to live longer or better?
  Clinics, 2014
• Toward Patient-Centered Drug Development in Oncology
  New England Journal of Medicine, 2013
• Missing Data and Measurement Variability in Assessing Progression-Free Survival Endpoint in Randomized Clinical Trials
  Clinical Cancer Research, 2013
• Randomized controlled trials in the era of molecular oncology: methodology, biomarkers, and end points
  Annals of Oncology, 2011
• New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
  European Journal of Cancer, 2009
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI: Journal of the National Cancer Institute, 2000
• The effect of measuring error on the results of therapeutic trials in advanced cancer
  Cancer, 1976